Can Massey Forge Consensus At NSF?

WASHINGTON--Walter Massey, poised to become the next director of the National Science Foundation, has succeeded in a series of tough jobs with an approach built on quiet attention to details and a commitment to reaching a consensus before taking action. It's a style of leadership that differs sharply from the outspoken and authoritarian method of Erich Bloch, whose six-year term ended August 31. And it's one that many scientists who know Massey say will serve him well as the foundation tries to

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"He has remarkable people skills," says physicist Gerald Garvey, a senior scientist at Los Alamos National Laboratory and a former associate director for research under Massey at Argonne National Laboratory. "It's quite a contrast to his predecessor at NSF. When you talk with him, you get a sense that the man is genuinely interested in your point of view. And he's very careful to make sure that all sides are being heard."

Adds Roland Schmitt, president of Rensselaer Polytechnic Institute, who served with Massey in the mid-1980s on the National Science Board, which oversees NSF, "He's not quite as blunt as Erich is, but both go after what they want. He'll try to seek a consensus before he acts, but he won't be pushed around."

At the same time, some colleagues wonder if Massey's preference to work for gradual change could prove insufficient to deal with the demands on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio